MOJ eISSN: 2374-6912 MOJCSR

Cell Science & Report
Editorial
Volume 1 Issue 2

Fluid secretion in epithelial cells: a key role of the Na-k-2cl cotransporter 1

Patrice G Bouyer
Department of Biology, Valparaiso University, USA
Received: June 23, 2014 | Published: June 24, 2014
Correspondence: Patrice G Bouyer, Valparaiso University, Department of Biology, Neils Science, Center, Rm 105A, 1610 Campus Drive East, Valparaiso, IN 46383 USA, Tel 2194645487, Fax 2194645489, Email
Citation: Bouyer PG. Fluid secretion in epithelial cells: a key role of the Na-k-2cl cotransporter 1. MOJ Cell Sci Rep. 2014;1(2):33. DOI: 10.15406/mojcsr.2014.01.00008

Abbreviations

NKCC1, Na-k-2cl cotransporter isoform 1; PKC, protein kinase c

Editorial

In epithelial cells such as those lining the colon or the upper airway, fluid secretion serves to lubricate and protect the surface of the epithelia. Dysfunction of fluid secretion is the hallmark of several human diseases (e.g., secretory diarrhea, cystic fibrosis or Sjogren’s syndrome). In secretory epithelia, fluid secretion is linked to transepithelial anions secretion (e.g., chloride or bicarbonate). For many years investigators have tried to manipulate anion secretion to treat fluid-associated disorders but with minimal success.

Although most of what we know about regulation of chloride secretion in epithelia derives from work on apical chloride channels (e.g., cystic fibrosis transmembrane regulator, bestrophin or TMEM16), the basolateral Na-K-2Cl cotransporter 1 (NKCC1) is the main chloride loading mechanism-bringing chloride above its electrochemical gradient for secretion by the apical chloride channels. Recent work on the regulation of NKCC1 demonstrates new pathways to control chloride secretion.

Dynamic regulation of plasma membrane proteins availability through endo/exocytosis and recycling represents a powerful mechanism for fine tuning cellular response (e.g., ion transport, hormone response). In colonic epithelial cells, activation of novel PKC delta (PKCδ) and epsilon (PKCε), but not the conventional PKC alpha, are responsible for the rapid internalization of NKCC1. Activation of PKCε causes a more profound inhibition of chloride secretion than PKCδ activation, demonstrating that chloride secretion can be fine-tuned according to the PKC isoform activated.1 Furthermore, NKCC1 internalization during PKC activation is clathrin-mediated which implies that NKCC1 is either subject to degradation or recycling.2 This finding has major consequences on the chloride secretion. Degradation of NKCC1 would imply prolong refractory period in chloride secretion, whereas recycling would provide a mean for rapid mobilization of NKCC1 and reestablishment of chloride secretion. Capsaicin, the pungent ingredient of hot pepper, also blunts chloride secretion by causing internalization of NKCC1 through an independent pathway of its usual target the Transient Receptor Potential Vanilloid type 1.3 Aside from the regulation of NKCC1 membrane expression, kinases are involved in the control of NKCC1 activity.4–6

Sustaining chloride secretion by preventing NKCC1 internalization may dramatically improve chloride secretion in cystic fibrosis during activation of other chloride channels or in settings aiming to rescue cystic fibrosis transmembrane regulator trafficking. On the other hand, activating pathways leading to NKCC1 internalization may prove to be useful drugs against secretory diarrhea. Therefore, understanding regulation of chloride secretion by NKCC1 may have important therapeutic applications.

Acknowledgements

None.

Conflict of interest

The author declares no conflict of interest.

References

©2014 Bouyer. This is an open access article distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and build upon your work non-commercially.
© 2014-2019 MedCrave Group, All rights reserved. No part of this content may be reproduced or transmitted in any form or by any means as per the standard guidelines of fair use.
Creative Commons License Open Access by MedCrave Group is licensed under a Creative Commons Attribution 4.0 International License.
Based on a work at https://medcraveonline.com
Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version | Opera |Privacy Policy